To include your compound in the COVID-19 Resource Center, submit it here.

BM32: Phase IIb ongoing

Biomay said an independent DMC recommended continuation of a double-blind, placebo-controlled, European Phase IIb trial of BM32 into

Read the full 180 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE